Navigation Links
Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16
Date:6/7/2011

SAN DIEGO, June 7, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will provide a company overview, discuss recent developments and review upcoming milestones at the 5th LHA Life Sciences & Medical Technologies Virtual Conference.  

(Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

The webcast presentation will be available Thursday, June 16, 2011, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) by visiting the Company's website at: www.aethlonmedical.com

Aethlon further disclosed that Company President Rodney S. Kenley will discuss the role of the Aethlon Hemopurifier® in the treatment of hepatitis C virus (HCV) in a presentation tomorrow at the 20th International Vicenza Course of Hemodialysis and CKD in Vicenza, Italy.  The Aethlon Hemopurifier® is first-in-class therapeutic filtration device that selectively removes infectious viruses and immunosuppressive toxins from the entire circulatory system through the use of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide. Mr. Kenley's presentation, "The Treatment of HCV with Affinity Plasmapheresis on Dialysis Machines," will focus on treating HCV in existing dialysis clinics with no change in infrastructure or capital investments.  The Hemopurifier® can be used to treat HCV in dialysis patients, in whom the prevalence of HCV is over 100 times higher than the general population, as well as non-dialysis patients.  Access to Mr. Kenley's slide presentation will be provided on the Aethlon Medical website after the conclusion of the event.

About Aethlon Medical

The Aethlon Medical mission
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
2. Aethlon Medical Clarifies News Report
3. ABC News Reports on Aethlon Medical
4. Aethlon Medical Announces Multi-Target Exosome Assay Validation
5. Aethlon Medical Releases Shareholder Letter
6. Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
7. Aethlon Medical Releases Shareholder Letter
8. Aethlon Medical to Host Investor Event on January 20, 2011
9. Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day
10. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
11. Aethlon Medical to Present at the Singular Research Fifth Annual Best of the Uncovereds Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015  Today, in final recognition of the ... Health Week, 1-800 Contacts is sharing how to keep ... lens wearers who do not properly care for their ... infections. Most contact lens wearers understand ... clean lens case is sometimes overlooked.  When proper steps ...
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by AstraZeneca plc, quetiapine ... important drug for the treatment of schizophrenia. Approved ... was listed in the Catalogue of Drugs for ...
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Quetiapine Market Investigation Report 2010-2019 2China Latanoprost Market Investigation Report 2015-2019 2
... the novel,selective relaxant binding agent (SRBA) being developed ... neuromuscular blockade as,compared to neostigmine in the Phase ... Spectrum, faster recovery from profound neuromuscular,blockade compared to ... were presented today at the 2007 annual meeting ...
... safety of nebulized,formoterol fumarate and safety/ efficacy of concomitant use with ... ... 16 Dey, L.P., a subsidiary of Mylan,Inc. (NYSE: MYL ... the annual scientific assembly of the American College of,Chest Physicians (ACCP) ...
Cached Medicine Technology:Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 2Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 3Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 4Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 5Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007 2Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007 3Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007 4Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007 5
(Date:8/29/2015)... York, NY (PRWEB) , ... August 29, 2015 , ... ... unofficial end of summer (which astronomically, officially ends on September 22nd this year). For ... summer-induced cyber security hangovers linger on which could prove far more costly than a ...
(Date:8/29/2015)... Houston, TX (PRWEB) , ... August 29, 2015 ... ... settlement allows the company to freely market and sell Arterosil and Arterosil HP, ... Daniels Health Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the ...
(Date:8/28/2015)... Richey, FL (PRWEB) , ... August 28, 2015 , ... ... many potential workers are qualified for the position they are applying for, they are ... of this, many employers are considering altering drug testing policies in order to be ...
(Date:8/28/2015)... Baltimore, MD (PRWEB) , ... August 28, 2015 , ... ... reduction system from Merz, received FDA clearance for results that last for two ... clearance is exciting news for patients who are looking for a long-lasting, effective solution ...
(Date:8/28/2015)... , ... August 28, 2015 , ... “ Frequentz ” ... at the latest and coolest applications on the market for iOS, Android, and Windows. ... shared with viewers how this software allows businesses to track product movement from beginning ...
Breaking Medicine News(10 mins):Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Track Product Movement from Beginning to End with Frequentz 2
... ... ... Hayes, Inc., the nation’s leading health technology research and consulting company, today announced that ... has joined the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC). The MEDCAC ...
... is not a replacement for HIV-specific drugs, researchers say , ... people who are infected with both HIV-1, a strain of ... benefit in more than one way by taking a herpes ... appears to also slow the progression of HIV. , ...
... , , , , , , ... ( SVA),a leading China -based vaccine manufacturer, today announced the ... land use,rights. The total consideration for the purchase is approximately ... working capital. The,initial payment of RMB56.5 million ( $8.3 ...
... ... covers annual dental cleanings , ... Canton, OH (PRWEB) February 15, 2010 -- Preventive care can serve as the best protection ... Pet Health Insurance makes this care even easier for pet parents to afford., , ,About ...
... , ... lawyers scrutinize the defect which causes Toyota made cars and trucks to accelerate when the ... ... of almost 2.3 million vehicles on January 21, because the company learned that accelerator pads ...
... ... CO2 fire extinguishers and extinguishers with frost-free horns. , ... Dartford, Kent (PRWEB) February 15, 2010 -- Fire ... fire extinguishers actually pose some safety hazards of their own: If incorrectly handled ...
Cached Medicine News:Health News:Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 3Health News:Pet Dental Month Prime Time To Schedule Preventive Annual Cleaning For Pets 2Health News:Toyota Recalls Millions of Defective Vehicles 2Health News:Toyota Recalls Millions of Defective Vehicles 3Health News:Fire Protection Online Resolves Safety Concerns with CO2 Fire Extinguishers 2
... for eyecare professionals- Winx Pro ... practice management system, using the ... Pro is a complete solution ... effectively managing the administrative, financial ...
The Advia 60 is designed to deliver powerful performance in a small package....
The XT-2000i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
Medicine Products: